secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2024-11-26T23:59:59+00:00
Accession:  0000899923-24-000060
Event type: litigation
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics derivative lawsuit settled; court approves $950k fee award, dismisses claims with prejudice
--------------------------------------------------------------------------------

- Court approves global settlement of shareholder derivative litigation; no admission of liability.
- Company pays $950,000 in attorneys' fees and expenses; adopts corporate governance reforms.
- Consolidated Delaware derivative actions and federal derivative action dismissed with prejudice.
- Settlement relates to complaints alleging fiduciary duty breaches by former and current directors/officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992324000060/0000899923-24-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992324000060/mygn-20241126.htm
  HTML page:      https://secwatch.observer/filing/0000899923-24-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer